NewzCommercial biohacking clinics in Riyadh are currently navigating significant fiscal challenges. These operational difficulties coincide with a broader global discourse regarding the efficacy and safety of high-profile longevity regimes, highlighted by recent revelations from prominent American tech entrepreneur Bryan Johnson.
Johnson, a well-known figure in the longevity space, recently expressed reservations about his own regimen following a diagnosis of a rare autoimmune disorder that causes his stomach lining to attack itself. This development has introduced new scrutiny into the viability and health implications of intensive biohacking practices within the commercial sector.
In-depth summary · AI, neutral